agilon health, inc.
AGL
$0.43
-$0.01-1.98%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.09% | 5.22% | 11.79% | 23.09% | 40.40% |
| Total Other Revenue | -12.33% | -1.11% | 0.37% | 14.39% | 42.18% |
| Total Revenue | -2.11% | 5.21% | 11.76% | 23.07% | 40.41% |
| Cost of Revenue | 0.61% | 6.15% | 14.81% | 25.31% | 42.60% |
| Gross Profit | -3,405.54% | -107.85% | -311.49% | -127.26% | -93.05% |
| SG&A Expenses | -12.06% | -13.19% | -13.00% | -11.81% | -7.44% |
| Depreciation & Amortization | 16.89% | 23.85% | 30.86% | 34.66% | 52.48% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.14% | 5.34% | 13.46% | 23.24% | 39.49% |
| Operating Income | -48.29% | -7.49% | -49.19% | -26.74% | -22.42% |
| Income Before Tax | -62.40% | -3.27% | -52.54% | -27.11% | -27.96% |
| Income Tax Expenses | -13.78% | 4,417.95% | -19.08% | -26.35% | 83.44% |
| Earnings from Continuing Operations | -61.96% | -3.83% | -51.95% | -26.47% | -28.18% |
| Earnings from Discontinued Operations | 242.51% | 119.83% | 116.40% | 116.24% | 85.46% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -100.00% | -100.00% | -117.54% | -124.15% |
| Net Income | -50.43% | 19.89% | -5.71% | 15.00% | 0.93% |
| EBIT | -48.29% | -7.49% | -49.19% | -26.74% | -22.42% |
| EBITDA | -52.50% | -6.34% | -50.82% | -25.35% | -20.19% |
| EPS Basic | -49.45% | 20.87% | -4.31% | 16.03% | 2.24% |
| Normalized Basic EPS | -49.43% | -1.07% | -50.34% | -24.04% | -22.45% |
| EPS Diluted | -49.45% | 20.94% | -3.36% | 16.95% | 4.10% |
| Normalized Diluted EPS | -49.43% | -1.07% | -50.34% | -24.04% | -22.29% |
| Average Basic Shares Outstanding | 0.73% | 0.92% | 1.10% | 1.00% | 0.50% |
| Average Diluted Shares Outstanding | 0.73% | 0.92% | 1.10% | 1.00% | -0.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |